Isoflurane

CHEMBL1256 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
184.5 g/mol
LogP
2.1
Phase
4

This halogenated ether is a widely used inhaled general anesthetic that maintains unconsciousness, muscle relaxation, and analgesia during surgery. It works by modulating multiple ion channels and neurotransmitter systems throughout the central nervous system. It is administered through a vaporizer in a precise concentration calibrated to the patient's needs.

Masse moléculaire

184,4900 g/mol

LogP

2,10

TPSA

9,20 Ų

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Mécanisme d'action

Produces reversible loss of consciousness and sensation through modulation of neuronal ion channels and receptor systems in the central nervous system, including GABA-A enhancement and NMDA receptor inhibition.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Produces reversible loss of consciousness and sensation through modulation of neuronal ion channels and receptor systems in the central nervous system, including GABA-A enhancement and NMDA receptor inhibition.

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

FC(F)OC(Cl)C(F)(F)F

InChI

InChI=1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2H

Molecular Formula

C3H2ClF5O

HBD / HBA

- / 6

Liaisons Rotatives

2

Atomes Lourds

10

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This halogenated ether is a widely used inhaled general anesthetic that maintains unconsciousness, muscle relaxation, and analgesia during surgery. It works by modulating multiple ion channels and neurotransmitter systems throughout the central nervous system. It is administered through a vaporizer in a precise concentration calibrated to the patient's needs.

Produces reversible loss of consciousness and sensation through modulation of neuronal ion channels and receptor systems in the central nervous system, including GABA-A enhancement and NMDA receptor inhibition.

Yes, Isoflurane is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1256. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3763. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.